Microarray-based transcriptional profiling of renieramycin M and jorunnamycin C, isolated from Thai marine organisms

Marine Drugs

Volumn 7, Issue 4, 2009, Pages 483-494

  Charupant, Kornvika ^a   Suwanborirux, Khanit ^a   Daikuhara, Naomi ^b   Yokoya, Masashi ^b   Ushijima Sugano, Rie ^c   Kawai, Takatoshi ^c   Owa, Takashi ^c   Saito, Naoki ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c EISAI CO LTD   (Japan)

Author keywords

Antitumor agent; Jorunnamycin C; Marine sponge; Oligonucleotide microarray; Renieramycin M

Indexed keywords

BIOLOGICAL MARKER; ISOQUINOLINE DERIVATIVE; JORUNNAMYCIN C; NATURAL PRODUCT; OLIGONUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE K; RENIERAMYCIN M; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DOWN REGULATION; DRUG ISOLATION; DRUG STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IC 50; MICROARRAY ANALYSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 75149193864     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md7040483     Document Type: Article

References (28)

1. Scott, J.D.; Williams, R.M. Chemistry and Biology of the Tetrahydroisoquionoline Antitumor Antibiotics. Chem. Rev. 2002, 102, 1669-1730.
2. Rinehart, K.L. Antitumor Compounds from Tunicates. Med. Drug. Rev. 2000, 20, 1-27.
3. Friedman, D.; Hu, Z.; Kolb, E.A.; Gorfajn, B.; Scotto, K.W. Ecteinascidin 743 Inhibits Activated but not Constitutive Transcription. Cancer Res. 2002, 62, 3377-3381.
4. Takebayashi, Y.; Pourquier, P.; Zimonjic, D.B.; Nakayama, K.; Emmert, S.; Ueda, T.; Urasaki, Y.; Kanzaki, A.; Akiyama, S.; Popescu, N.; Kraemer, K.H. Pommier, Antiproliferativity of Ecteinascidin 743 Is Dependent upon Transcription-Coupled Nucleotide-Excision Repair. Nat. Med. 2001, 7, 961-966.
5. Aune, G.J.; Furuta, T.; Pommier, Y. Ecteinascidin 743: A Novel Anticancer Drug with a Unique Mechanism of Action. Anticancer Drugs 2002, 13, 545-555.
6. Gajate, C.; An, F.; Mollinedo, F. Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743. J. Biol. Chem. 2002, 277, 41580-41589.
7. Jimeno, J.; Faircloth, G.; Fernandez Sousa-Faro, J.M.; Scheuer, P.J.; Rinehart, K. New Marine Derived Anticancer Therapeutics - A Journey from the Sea to Clinical Trials. Mar. Drugs 2004, 2, 14-29.
8. Fayette, J.; Coquard, I.R.; Alberti, L.; Ranchère, D.; Boyle, H.; Blay, J.Y. ET-743: A Novel Agent with Activity in Soft Tissue Sarcomas. Oncologist 2005, 10, 827-832.
9. David-Cordonnier, M.-H.; Gajate, C.; Olmea, O.; Laine, W.; de la Iglesia-Vicente, J.; Perez, C.; Cuevas, C.; Otero, G.; Manzanares, I.; Bailly, C.; Mollinedo, F. DNA and Non-DNA Targets in the Mechanism of Action of the Antitumor Drug Trabectedin. Chem. Biol. 2005, 12, 1201-1210.
10. Guirouin-Barbat, J.; Antony, S.; Pommier, Y. Zalypsis (PM00104) is a Potent Inducer of γ-H2AX foci and Reveals the Importance of the C Ring of Trabectedin for Transcription-coupled Repair Inhibition. Mol. Cancer Ther. 2009, 8, 2007-2014, also see http://www.pharmamar.com/ en/pipeline/zalypsis.cfm.
11. Martinez, E.J.; Owa, T.; Schreiber, S.L.; Corey, E.J. Phthalascidin, a Synthetic Antitumor Agent with Potency and Mode of Action Comparable to Ecteinascidin 743. Proc. Natl. Acad. Sci. USA 1999, 96, 3496-3501.
12. Martinez, E.J.; Corey, E.J.; Owa, T. Antitumor Activity and Gene Expression-Based Profiling of Ecteinascidin 743 and Phthalascidin Pt 650. Chem. Biol. 2001, 8, 1151-1160.
13. Plowright, A.T.; Schaus, S.E.; Myers, A.G. Transcriptional Response Pathways in a Yeast Strain Sensitive Saframycin A and a More Potent Analog Evidence for a Common Based of Activity. Chem. Biol. 2002, 9, 607-618.
14. He, H.; Faulkner, D.J. Renieramycins E and F from the Sponge Reniera sp: Reassignment of the Stereochemistry of the Renieramycins. J. Org. Chem. 1989, 54, 5822-5824.
15. Frincke, J.M.; Faulkner, D.J. Antimicrobial Metabolites of the Sponge Reniera sp. J. Am. Chem. Soc. 1982, 104, 265-269.
16. Fontana, A.; Cavaliere, P.; Wahidulla, S.; Naik, C.G.; Cimino, G. A New Antitumor Isoquinoline Alkaloid from the Marine Nudibranch Jorunna funebris. Tetrahedron 2000, 56, 7305-7308.
17. Suwanborirux, K.; Amnuoypol, S.; Plubrukarn, A.; Pummangura, S.; Kubo, A.; Tanaka, C.; Saito, N. Chemistry of Renieramycins. Part 3. Isolation and Structure of Stabilized Renieramycin Type Derivatives Possessing Antitumor Activity from Thai Sponge, Xestospongia Species Pretreated with Potassium Cyanide. J. Nat. Prod. 2003, 66, 1441-1446.
18. Amnuoypol, S.; Suwanborirux, K.; Pummangura, S.; Kubo, A.; Tanaka, C.; Saito, N. Chemistry of Renieramycins. Part 5. Structure Elucidation of Minor Components of Renieramycins O and Q-S, from Thai Marine Sponge, Xestospongia Species, Pretreated with Potassium Cyanide. J. Nat. Prod. 2004, 67, 1023-1028.
19. Charupant, K.; Daikuhara, N.; Saito, E.; Amnuoypol, S.; Suwanborirux, K.; Owa, T.; Saito, N. Chemistry of Renieramycins. Part 8. Synthesis and Cytotoxicity Evaluation of Renieramycin M-Jorunnamycin A Analogues. Bioorg. Med. Chem. 2009, 17, 4548-4558.
20. Charupant, K.; Suwanborirux, K.; Amnuoypol, S.; Saito, E.; Kubo, A.; Saito, N. Jorunnamycins A-C, New Stabilized Renieramycin-Type Bistetrahydroisoquinolines Isolated from the Thai Nudibranch Jorunna funebris. Chem. Pharm. Bull. 2007, 55, 81-86.
21. Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65, 55-63.
22. 50 value (the concentration required to inhibit cell growth by 50%) was determined by the least squares method.
23. 24 primer. The cDNA product was purified by phenol/chloroform/isoamyl alcohol extraction. In vitro transcription was carried out by means of a GeneChip IVT Labeling kit (Affymetrix). The resulting biotin-labeled cRNA was purified using the RNeasy kit. cRNA was fragmented at 94 °C for 35 min, and then hybridized for 16 h onto an Affymetrix GeneChip Human Genome Focus array that is capable of probing approximately 8,500 transcripts. The probe arrays were washed and stained with streptavidin-phycoerythrin and biotinylated goat anti-streptavidin on an Affymetrix Fluidics Station. Fluorescence intensities were captured with a Hewlett-Packard confocal laser scanner. All quantitative data were processed using the robust multi-array average (RMA) method [27], and transcriptional signature was defined as the differences between the data for compound treatment and those for DMSO treatment (control) on a logarithmic scale. Hierarchical clustering of the obtained transcriptional signatures for all test samples was done using the unweighted pair grouping method with arithmetic mean (UPGMA) in GeneSpring software to afford a dendrogram (tree graph) based on the similarity (cosine correlation). Up- and down-regulated genes were selected according to the following criteria: i) at least twofold change compared with control data; and ii) statistical significance with p-value < 0.05 by the t-test in triplicate data. Gene Ontology (GO) analysis was used to illuminate compound-related biological processes, cellular components, and molecular functions. Enriched GO terms with Benjamini-Hochberg adjusted p-values < 0.05 were selected using the Bioconductor GOstats library [28].
24. Xu, Y.; Tan, L.J.; Grachtchouk, V; Voorhees, J.J.; Fisher, G.J. Receptor-type Protein-tyrosine Phosphatse-K regulates Epidermal Growth Factor Receptor Function. J. Biol. Chem. 2005, 280, 42694-42700.
25. Martínez, N.; Sánchez-Beato, M.; Carnero, A.; Moneo, V.; Tercero, J.C.; Fernández, I.; Navarrete, M.; Jimeno, J.; Piris, M.A. Transcriptional Signature of Ecteinascidin 743 (Yondelis, Trabectedin) in Human Sarcoma Cells Explanted from Chemo-Naive Patients. Mol. Cancer Ther. 2005, 4, 814-823.
26. Owa, T.; Yokoi, A.; Yamazaki, K.; Yoshimatsu, K.; Yamori, T.; Nagasu, T. Array-Based Structure and Gene Expression Relationship Study of Antitumor Sulfonamide Including N-[2-(4-hydroxyphenyl)amino]3-pyridinyl]-4- methoxybenzenesulfonamide and N-(3-Chloro-7-indolyl)-1,4- benzenedisulfonamide. J. Med. Chem. 2002, 45, 4913-4922.
27. Irizarry, R.A.; Hobbs, B.; Collin, F.; Beazer-Barclay, Y.D.; Antonellis, K.J.; Scherf, U. Exploration, Normalization, and Summaries of High Density Oligonucleotide Array Probe. Biostatistic 2003, 4, 249-264.
28. Gentleman, R. Using GO for Statistical Analyses. In Proceedings of COMPSTAT 2004 Symposium, 2004; pp. 171-180, also see http://comostat2004. cuni.cz/.